Source - SMW
NetScientific said one of its portfolio companies, Glycotest, has been granted a Japanese patent for its core technology for early detection of life threatening liver disease.

Glycotest now holds a total of six patents in Australia, the US and Japan, covering the use of over 50 unique glycoprotein biomarkers for the diagnosis of liver cancers and other liver diseases.  

Related Charts

Netscientific (NSCI)

0.00p (0.00%)
delayed 18:15PM